Rab11a sustains GSK3 β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer
In conclusion, the present study demonstrated that Rab11a promotes aggressiveness of pancreatic cancer through GSK3β/Wnt/β-catenin signaling pathway.
Source: Tumor Biology - Category: Cancer & Oncology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Genetics | Molecular Biology | Pancreas | Pancreatic Cancer | Study